Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Reina Mizuno"'
Autor:
Taku Homma, Reina Mizuno, Yu Miyama, Tomonari Suzuki, Eita Uchida, Jun‐ichi Adachi, Masanori Yasuda
Publikováno v:
Clinical Case Reports, Vol 9, Iss 1, Pp 380-385 (2021)
Abstract Pediatric supratentorial ependymomas often have a clear cell morphology and reveal a RELA fusion. When a clear cell neoplasm is intraoperatively diagnosed, intracytoplasmic dot‐like inclusions by cytology are a useful cytopathological feat
Externí odkaz:
https://doaj.org/article/df9eaa81ee4244939a2a45ce2945c619
Autor:
Reina Mizuno, Daisuke Sugiura, Kenji Shimizu, Takumi Maruhashi, Mizuki Watada, Il-mi Okazaki, Taku Okazaki
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Cancer-immunotherapy targeting programmed cell death 1 (PD-1) activates tumor-specific T cells and provides clinical benefits in various cancers. However, the molecular basis of PD-1 function is still enigmatic. Especially, it is unclear which signal
Externí odkaz:
https://doaj.org/article/c0d7da358b534ea39efc29d64154b03a
Autor:
Keijiro Yoshida, Tomonari Suzuki, Hiroki Sato, Hiroki Kobayashi, Reina Mizuno, Mitsuaki Shirahata, Tatsuya Ozawa, Kazuhiko Mishima
Publikováno v:
Neurohirurgija - The Serbian Journal of Neurosurgery. 3
Introduction: Primary pituitary lymphoma (PPL) is a rare disease characterized by lymphoma confined to the sella or parasellar region without systemic involvement. The clinical symptoms of PPL may include headache, hypopituitarism, visual field distu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32d66e070e414b25cecef9e7a20f57ed
https://doi.org/10.55005/v3i1.7
https://doi.org/10.55005/v3i1.7
Autor:
Ryosuke Tsuchiya, Kazuhiko Mishima, Atsushi Sasaki, Taku Homma, Reina Mizuno, Eita Uchida, Mitsuaki Shirahata, Tomonari Suzuki, Junichi Adachi, Ryo Nishikawa
Publikováno v:
Japanese Journal of Neurosurgery. 31:42-49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c2c6c5ec2b82ee304a1923f17bd7ddc
https://doi.org/10.7887/jcns.31.42
https://doi.org/10.7887/jcns.31.42
Autor:
Reina Mizuno, Taku Homma, Jun-ichi Adachi, Kazuhiko Mishima, Tomonari Suzuki, Mitsuaki Shirahata, Ryo Nishikawa, Sasaki Atushi
Publikováno v:
Journal of Neurosurgery: Case Lessons. 4
BACKGROUND The revised fourth edition of the World Health Organization classification of central nervous system tumors was published in 2016. Based on this classification, one of the infiltrating glioma entities named “oligoastrocytoma/anaplastic o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9550a8de0418134379446f79c7b3806f
https://doi.org/10.3171/case22146
https://doi.org/10.3171/case22146
Autor:
Kazuhiko Mishima, Naoki Tkahashi, Mitsuaki Shirahata, Tomonari Suzuki, Reina Mizuno, Junichi Adachi, Tastuya Ozawa
Publikováno v:
Neuro-Oncology Advances. 4:iii21-iii21
Background Many patients with primary CNS lymphoma (PCNSL) relapse despite complete response (CR) after initial therapy. Relapsed PCNSL (rPCNSL) has a poor prognosis, and no adequate standard of treatment has been established. Autologous stem cell tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39e9b3d124d25a491d33510746b0d1c1
https://doi.org/10.1093/noajnl/vdac167.080
https://doi.org/10.1093/noajnl/vdac167.080
Autor:
Takumi Maruhashi, Mizuki Watada, Reina Mizuno, Kenji Shimizu, Taku Okazaki, Il-mi Okazaki, Daisuke Sugiura
Publikováno v:
Biochemical and Biophysical Research Communications. 511:491-497
Cancer immunotherapies targeting programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte antigen 4 revolutionized cancer treatment and instigated various trials to develop new cancer immunotherapies with higher therapeutic efficacy. Agonistic Abs a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4eb0fc390c60a6e2ab69534c20ec6f
https://doi.org/10.1016/j.bbrc.2019.02.004
https://doi.org/10.1016/j.bbrc.2019.02.004
Autor:
Hikari, Okamura, Il-Mi, Okazaki, Kenji, Shimizu, Takumi, Maruhashi, Daisuke, Sugiura, Reina, Mizuno, Taku, Okazaki
Publikováno v:
Journal of autoimmunity. 105
Anti-PD-1 therapy can induce eradication of tumors and immune-related adverse events (irAEs) in humans and model animals. However, how anti-PD-1 therapy modifies cellular phenotypes of CD8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::821168d08ff4f25884dfe91aabc844a5
https://pubmed.ncbi.nlm.nih.gov/31277964
https://pubmed.ncbi.nlm.nih.gov/31277964
Autor:
Takumi Maruhashi, Daisuke Sugiura, Kenji Shimizu, Il-mi Okazaki, Taku Okazaki, Mizuki Watada, Reina Mizuno
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology
Frontiers in Immunology
Cancer-immunotherapy targeting programmed cell death 1 (PD-1) activates tumor-specific T cells and provides clinical benefits in various cancers. However, the molecular basis of PD-1 function is still enigmatic. Especially, it is unclear which signal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1a7980c5a742221fa1594dc7b63ee0
https://pubmed.ncbi.nlm.nih.gov/31001256
https://pubmed.ncbi.nlm.nih.gov/31001256
Autor:
Daisuke Sugiura, Taku Okazaki, Hikari Okamura, Kenji Shimizu, Reina Mizuno, Takumi Maruhashi, Il-mi Okazaki
Publikováno v:
Journal of Autoimmunity. 105:102296
Anti-PD-1 therapy can induce eradication of tumors and immune-related adverse events (irAEs) in humans and model animals. However, how anti-PD-1 therapy modifies cellular phenotypes of CD8+ T cells to destroy tumors and damage self-tissues remains to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8f8a05cce36a388e3b48762573ef6c4
https://doi.org/10.1016/j.jaut.2019.06.007
https://doi.org/10.1016/j.jaut.2019.06.007